文献速递骨科与运动康复疼痛康复神经康复

肌肉骨骼康复人群镇痛药使用的大型描述性研究

Analgesic consumption in a large sample of people in musculoskeletal rehabilitation: A descriptive study.
PubMed 文献 · Ann Phys Rehabil Med · 2023-12-20

该回顾性研究纳入4350例伤后住院康复者,按镇痛药使用分为无镇痛药、非阿片类和阿片类三组。20%使用阿片类,曲马多为主,吗啡当量中位剂量8.3 mg/天;症状严重度、焦虑抑郁、灾难化思维及神经病理性疼痛比例随组别递增。8年间阿片类处方未增加。

要点

  • 康复住院人群中20%使用阿片类镇痛药,40%用非阿片类,40%未用镇痛药。
  • 阿片类组以曲马多为主,吗啡当量中位剂量8.3 mg/天。
  • 疼痛严重度、焦虑抑郁、灾难化思维和神经病理性疼痛比例从无镇痛药到阿片类组逐步升高。

核心结论

  • 康复住院人群中阿片类使用与更高疼痛严重度、焦虑抑郁、灾难化思维及神经病理性疼痛相关。
  • 8年间阿片类处方未增加,提示处方模式稳定。

研究设计与样本

  • 回顾性研究,为期8年,纳入4350例伤后住院康复者,按镇痛药使用分为无镇痛药、非阿片类和阿片类三组。
  • 采用方差分析或卡方检验比较三组。

主要发现

  • 20%使用阿片类,40%使用非阿片类,40%未使用镇痛药。
  • 阿片类组主要使用曲马多,吗啡当量中位剂量8.3 mg/天。
  • 非阿片类组主要使用对乙酰氨基酚和布洛芬。
  • 症状(疼痛严重度/干扰、焦虑/抑郁、灾难化思维)从无镇痛药到非阿片类再到阿片类组逐步加重。
  • 阿片类组神经病理性疼痛患病率高于其他两组。

临床怎么用

  • 康复 setting 中应关注可干预因素(焦虑抑郁、灾难化思维、神经病理性疼痛)以优化镇痛管理。
  • 阿片类处方未随时间增加,提示当前处方模式相对稳定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Consumption of opioids is increasing worldwide in people with chronic non-cancer pain, although their effectiveness is debated. OBJECTIVES: The aim of the current study was to evaluate analgesic consumption and its association with different variables (demographic variables, pain, anxiety/depression, catastrophism, and kinesiophobia), in the field of musculoskeletal rehabilitation, where no data are available. METHODS: This was a retrospective study over a period of 8 years on people hospitalised for rehabilitation after injury. Participants were classified into 3 categories: no analgesics (NA), non-opioid analgesics (NOA), and opioid analgesics (OPA). ANOVA or chi-squared tests were used to compare the 3 groups. RESULTS: A total of 4,350 people (84% men; mean [SD] age, 44 [11] years) were included. In total, 20% were taking OPA, 40% NOA and 40% NA. In the OPA group, tramadol was mainly used, and the morphine equivalent median dose was 8.3 mg/day. In the NOA group, paracetamol and ibuprofen were mostly used. Symptoms increased progressively across the 3 groups (NA/NOA/OPA), with increased levels of pain severity/interference, anxiety/depression and catastrophizing, and a higher prevalence of neuropathic pain in the OPA group versus the others. CONCLUSIONS: These results are consistent with those found in groups of people with chronic pain taking larger doses of opioids and following opioid reduction or cessation programs. Opioid prescription did not increase over the 8 years, which was reassuring. These factors are important to emphasise because they can be modified in the rehabilitation setting with interdisciplinary management. REGISTRATION: Our database was registered on Mendeley Data.

来源:Ann Phys Rehabil Med,查看原文。版权归原作者所有。

引用

  1. Konzelmann M, Vuistiner P, Burrus C, et al. Analgesic consumption in a large sample of people in musculoskeletal rehabilitation: A descriptive study. Ann Phys Rehabil Med. 2023. PMID: 38118341. doi:10.1016/j.rehab.2023.101776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。